Global TCR-Based Antibody Market Analysis By Target Antigen (NY-ESO-1, p53, WT-1, Ebv), By Indication (Bladder Cancer, Multiple Myeloma, Ovarian Cancer, Nasopharyngeal Carcinoma, Other Indications), By End-Users (Hospitals, Specialized Clinics, Pharma & Biotech Research Laboratories, Gene Therapy Centers), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Feb 2024
- Report ID: 84335
- Number of Pages: 227
- Format:
-
-
-
- Lion TCR
- GlaxoSmithKline
- Adaptimmune Therapeutics PLC
- Celgene Corporation
- Immunocore
- Kuur Therapeutics Limited
- Lion TCR Pte. Ltd.
- Kite Pharma
- Takara Bio Inc.
- Ziopharm Oncology Inc.
- Merck & Co. Inc.
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible